---
schema_version: "secwatch.filing_event.v1"
accession: "0001625101-22-000070"
form_type: "8-K"
ticker: "PLSE"
cik: "0001625101"
company_name: "PULSE BIOSCIENCES, INC."
filed_at: "2022-12-06T23:59:59+00:00"
generated_at: "2026-06-21T08:55:12.051459+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Pulse Biosciences CFO Sandra Gardiner resigns; search for successor underway

## Summary
- Sandra Gardiner, CFO of Pulse Biosciences, resigned on November 30, 2022.
- Resignation not due to any disagreement with the company on operations or accounting.
- Company expects to promptly begin a search for Ms. Gardiner’s successor.

## SEC filing metadata
- accession: 0001625101-22-000070
- form_type: 8-K
- ticker: PLSE
- cik: 0001625101
- company_name: PULSE BIOSCIENCES, INC.
- filed_at: 2022-12-06T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1625101/000162510122000070/0001625101-22-000070-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1625101/000162510122000070/plse-20221130x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001625101-22-000070
- JSON: https://secwatch.observer/filing/0001625101-22-000070.json
- Plain text: https://secwatch.observer/filing/0001625101-22-000070.txt

## Key facts
- Executive change
  Sandra Gardiner resigned as Chief Financial Officer at PULSE BIOSCIENCES, INC..
  - Action: resigned
  - Role: Chief Financial Officer
  source text: On November 30, 2022, Sandra Gardiner, the Chief Financial Officer of Pulse Biosciences, Inc. (the “Company”) gave notice that she was resigning from the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1625101/000162510122000070/0001625101-22-000070-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.